Carnitine is a cofactor in the transport of long-chain fatty acids through the mitochondrial membrane for oxidation.
To assess these determinants of fat utilization during total parenteral nutrition, lipoprotein and hepatic lipase activities and carnitine concentrations of nine newborn infants, operated on because of gastrointestinal anomalies during the first day of life, were measured with specific methods. Total parenteral nutrition was built up in 3 days whereafter the infants received 3 g/kg of fat at a constant rate of infusion for 24 h/day. Lipoprotein lipase activity of postheparin plasma increased from 14 to 35 pmol free fatty acids/ml/h during parenteral nutrition whereas hepatic lipase activity remained unchanged at 40 pmol free fatty acids/ml/h. Serum free carnitine and acylcarnitine levels decreased significantly during parenteral nutrition; urinary excretion of carnitine decreased also. In addition, serum cholesterol and phospholipids increased markedly during parenteral nutrition whereas serum triglycerides, free fatty acids, and blood B-hydroxybutyrate remained unchanged. Lipoprotein lipase is the rate-limiting factor for clearance of fat from the circulation; it hydrolyzes triglycerides of lipoproteins and fat emulsion particles to glycerol and free fatty acids (4, 19) . Carnitine is essential for facilitated transport of long-chain free fatty acids across the mitochondrial membrane (9) .
Lipoprotein lipase in newborn infants is usually estimated by determining postheparin plasma lipolytic activity (6, 8) . Postheparin plasma, however, contains hepatic lipase too (14, 26) . The function of hepatic lipase is unsettled (1 1, 15, 16, 18, 19) but its activity in infants is about three times the activity of lipoprotein lipase (26, 27) . In addition, these two lipases can vary independently (26, 27) . Hence, postheparin plasma lipolytic activity is an inadequate measure of lipoprotein lipase.
Adults can synthesize the carnitine they need. Therefore, carnitine is not considered an essential nutrient. Newborn infants may not, however, be capable of sufficient carnitine synthesis. Therefore, infants may be dependent on nutritional sources of carnitine, such as milk. Infants receiving carnitine-free total parenteral nutrition are at risk of developing carnitine deficiency characterized by decreased blood concentration and tissue content of carnitine (2, 20, 24, 28) . Reduced carnitine intake may impair fatty acid oxidation and diminish ketogenesis after fat infusion; these deficiencies can be corrected with supplementary carnitine (23, 29) .
To study the role of the principal regulators of fat metabolism in newborn infants lipoprotein lipase and hepatic lipase activities and carnitine concentrations were measured during parenteral nutrition.
PATIENTS AND METHODS

Patients.
The patients were nine newborn infants who required surgical operation and parenteral nutrition because of gastrointestinal tract anomalies (Table 1) . Surgery was performed under general anesthesia during the first day of life. For subsequent parenteral nutrition seven infants received central venous catheters and two infants (patients 4 and 5) peripheral venous catheters; none had a continuous heparin infusion. After the opera- tion the infants were transferred to the intensive care unit and treated in a respirator during the first 2 days of life. Three infants (patients 2, 6, and 8) needed respiratory support for one week because of abdominal distension. Four of the infants needed phototherapy because of hyperbilirubinemia; one of them (patient 5) had blood group incompatibility. Parenteral nutrition. During the first 2 days of life the infants received 10% glucose infusion. Parenteral nutrition was started on the 3rd day and built up during 3 days: amino acid and fat infusions were increased by 1 g/kg per day. Amino acids were given as 8.9% crystalline solution (Aminosteril 11, Medipolar, Oulu, Finland), and fat as 10% emulsion of soybean oil (Intralipid, Kabi Vitrum, Sweden). After the build-up all infants received 2.7 g/kg of amino acids, and 3 g/kg of fat at a constant rate of infusion each 24 h. The rate of glucose infusion was adjusted according to individual tolerance. During the first 3 days of life the amount of nonnitrogen calories (two-thirds from glucose as 10-30% solution) was about 40 kcal/kg/day, between the 4th and 9th day 60-70 kcal/kg/day, and after the 10th day 80-100 kcal/kg/day. The total volume of infusion was 100-150 ml/kg/day. In addition, the infants received normal daily allowances (7) of minerals (Na, K, Ca, P, Mg), trace minerals (Tracefusin, Leiras, Turku, Finland), and vitamins (Soluvit and Vitalipid Infant, KabiVitrum Sweden). On the average, weight gain started at the age of 5 days and was 16 g/day. Serum ureanitrogen concentration remained below 15 mg/dl during parenteral nutrition.
Blood and urine samples. During the first 2-3 wk of parenteral nutrition blood samples of 2-3 ml were taken every other day. Later, blood samples were taken once a week. Routine laboratory measures (7) and concentrations of serum triglycerides, cholesterol, apolipoproteins A-I, A-11, and B, phospholipids, free fatty acids, free carnitine and acylcarnitine, and blood phydroxybutyric acid were determined from these samples.
After discontinuation of parenteral nutrition, when the infants had been solely on breast milk for 1 wk, blood samples were taken from patients 1-6 for measuring serum cholesterol, phospholipids, apolipoproteins A-I, A-11, and B, and free carnitine and acylcarnitine.
Plasma lipoprotein and hepatic lipase activities and serum insulin were measured once before the beginning of parenteral nutrition with fat emulsion and amino acid solution. The measurement was repeated once between the 4th and 9th day, once between the 10th and 20th day, and later once a month. Each time a blood sample was first taken to measure serum insulin and the basal activities of the lipases. Then a heparin dose of 100 IU/kg was given intravenously. Fifteen minutes later a blood sample was taken to measure lipase activities. Fat infusion was discontinued for 2 h before and after heparin administration.
Urine was collected for 24 h before the beginning of parenteral nutrition with fat emulsion and amino acid solution. The collection was repeated during the 10th day and thereafter once a month (patients 7 and 8). Total carnitine concentrations were determined from these samples.
Biochemical assays. Serum triglyceride and cholesterol concentrations were measured with an enzymatic method (commercial reagent kit no. 1873 13 for cholesterol and no. 29771 for triglycerides, Boehringer Diagnostics GmbH, Mannheim, West Germany). Serum phospholipid concentration was measured as inorganic phosphate (1). Serum apolipoprotein A-I, A-11, and B concentrations were measured with a radial immunodiffusion method (3, 5) . Serum free fatty acid concentration was measured with an enzymatic method (Nefa C-Test, Wako, Wako Pure Chemical Industries LTD, Japan). Blood Bhydroxybutyric acid concentration was measured with a fluorometric method (21) . Serum insulin concentration was measured using radioimmunoassay (commercial kit, Amersham, Bucks, England). Free and total carnitine concentrations were measured with the method of McGarry and Foster (1 7) modified according to Novak et al. (20) for both serum and tissue. Acylcarnitine was calculated by subtracting free carnitine from total carnitine. Postheparin plasma lipoprotein and hepatic lipase activities were measured with the immunochemical method of Huttunen et al. (14) : lipoprotein lipase was measured after inactivating hepatic lipase with a specific antiserum; hepatic lipase was measured at 1 M NaCl concentration inactivating lipoprotein lipase, no serum was added. The activities are expressed in pmol of free fatty acid released from radioactive triolein substrate per 1 ml of plasma in 1 h.
Statistical analysis. One-way analysis of variance for repeated measures with age group as a within factor was performed under the assumption of normal distribution with P2-V of the BMDP statistical software.
The study protocol was approved by the Ethical Committee of the Children's Hospital, University of Helsinki. (Fig. 1A) and phospholipid ( Fig. 1 B) concentrations increased markedly ( p < 0.0001) during parenteral nutrition. In contrast, serum triglyceride, free fatty acid, and blood 0-hydroxybutyrate levels (Fig. 2) 
RESULTS
Serum cholesterol
eficientlv.
~u r i n g parenteral nutrition apolipoprotein A-I (Fig. 3A) remained practically unchanged, apolipoprotein A-I1 (Fig. 3B ) first 3 days) were normal (25, 26) before the beginning of the infusion increased and then decreased ( p < 0.05), and apolipoprotein B of fat emulsion and amino acids. During parenteral nutrition (Fig. 3C) increased monotonically ( p < 0.05) .
lipoprotein lipase activity (Fig. 4A) increased considerably ( p <
The mean lipoprotein and hepatic lipase activities (Fig. 4 , 0-0.01), whereas hepatic lipase activity (Fig. 4 8 ) remained con- stant. However, after 3 wk hepatic lipase activity decreased considerably in the two infants (patients 7 and 8) who were still under parenteral nutrition.
LIPASES AND CARNITINE DURING PARENTERAL NUTRITION L i p o p r o t e i n lipase
The decrease of serum insulin concentration (Fig. 5 ) during parenteral nutrition was not statistically significant.
Serum total, free, and acylcarnitine concentrations all decreased significantly ( p < 0.01) during parenteral nutrition (Fig. 6) . Total carnitine excretion in urine at 0-3 days of age was on the average 1 14 nmol/mg of creatinine, and by the age of 10 days it decreased ( p < 0.05) to 68 nmol/mg of creatinine.
During parenteral nutrition there was a low (14.5 pmol/liter) serum carnitine concentration and no measurable urinary excretion of carnitine in one infant (patient 7) who died at the age of 5 months. Her total carnitine concentrations in muscle (27 nmol/ mg of protein or 12 nmol/mg of dry weight) and heart (7.2 nmol/mg of protein or 4.9 nmol/mg of dry weight) were, however, normal when compared with five muscle biopsies from adults (1 9 nmol/mg of protein; SEM 2.0 or 13 nmol/mg of dry weight; SEM 1.1) and three heart muscle samples (6.7 nmol/mg of protein; SEM 1.1 or 3.1 nmol/mg of dry weight; SEM 1.4) from autopsied infants.
After parenteral nutrition the concentration of cholesterol (n = 5) and apolipoproteins B and A-I1 (n = 4) were as during parenteral nutrition. In contrast, phospholipid level ( n = 4 ) decreased ( p < 0.05) from 300 to 160 mg/dl and apolipoprotein A-I (n = 4) increased ( p < 0.05) from 77 to 110 mg/dl. Also, serum concentration of free carnitine (n = 4) increased ( p < 0.05) from 10.9 to 20.9 pmol/liter, whereas the increases in total carnitine and acylcarnitine were not statistically significant.
DISCUSSION
In agreement with Griffin et al. (13), it was found that serum cholesterol and phospholipids increased markedly in newborn infants during parenteral nutrition, which may result from fat emulsion infusion.
Apolipoprotein concentrations have not been measured previously in newborn infants during parenteral nutrition. I found that the concentration of apolipoprotein A-I remained constant, apolipoprotein A-I1 first increased and then decreased, and apolipoprotein B increased monotonically with age. Hence, during short-term parenteral nutrition apolipoproteins A-I and A-I1 seem to behave as in adults (30). The increase of apolipoprotein B may result, at least partially, from the increase of cholesterol and phospholipids that occurs in low density lipoproteins ( 1 3) because apolipoprotein B is the major protein moiety of low density lipoproteins. In breast-fed newborn infants the concentrations of apolipoproteins A-I, A-11, and B increase progressively with postnatal age (31). These apolipoproteins are in part synthesized in the intestine (12), which might explain why these apolipoproteins do not behave similarly during breast-feeding and paienteral nutrition.
Lipoprotein lipase activity has not been previously measured during parenteral nutrition in infants. I found that plasma lipoprotein lipase activity increased considerably during parenteral nutrition. This accounts for the increase of postheparin lipolytic activity that occurs in infants during parenteral nutrition (8). Also, lipoprotein lipase activity of adipose tissue has been shown to increase during parenteral nutrition in adults (30). The increase of lipoprotein lipase activity observed may relate to increasing daily caloric intake (8). However, in the present study the increase of lipase activity leveled off before caloric intake reached a steady state. On the other hand, it has been proposed that fat infusion induces lipoprotein lipase activity (8, 30). In agreement, the increase of lipoprotein lipase activity coincided with the beginning of fat infusion. Moreover, insulin is a known inducer of lipoprotein lipase (10). However, basal insulin concentrations, in contrast to lipoprotein lipase, did not increase during parenteral nutrition.
Triglyceride levels were high only occasionally during the first days of parenteral nutrition. Similarly, preterm infants younger than 1 wk of age seem to develop high peak levels of plasma triglycerides during fat infusion (25). These two findings are in agreement with the age-dependent increase of lipoprotein lipase activity found during parenteral nutrition (8) and suggest that lipoprotein lipase activity is not rate-limiting, except for the first days of parenteral nutrition.
Hepatic lipase activity has not previously been measured during parenteral nutrition. It was found that the activity of this enzyme remained unchanged during parenteral nutrition. However, after 3 wk hepatic lipase activity decreased considerably in the two infants who were still under parenteral nutrition. The decrease may result either from cholestatic liver damage that both infants had or from the increase of age because hepatic lipase activity in infants is higher than in adults (26, 27).
In accordance with previous studies (20, 22, 28, 29) , it was found that carnitine concentrations in serum and urine decreased considerably during parenteral nutrition. Decreased serum carnitine in preterm infants has been reported to be associated with impaired fatty acid oxidation (22, 29). Because free fatty acid and 8-hydroxybutyric acid concentrations remained unchanged during parenteral nutrition, it is possible that low serum carnitine does not, in fact, reflect a shortage of carnitine in tissue. In agreement, the only infant autopsied had normal skeletal and heart muscle carnitine concentrations despite low serum and urinary levels. Thus, the rate-limiting role of carnitine remains unproven under the present circumstances. This conclusion is in agreement with the findings of Orzali et al. (23) .
